AUDUBON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a number one musculoskeletal options firm, celebrated twenty years of the NuVasive XLIF process on the Society for Minimally Invasive Backbone Surgical procedure (SMISS) ’23 Annual Discussion board.
“Only a few medical expertise improvements have remodeled an {industry} just like the NuVasive XLIF process. Twenty years of XLIF has produced 20 years of unmatched medical validation, represented by an unimaginable physique of proof on the reproducibility, security, and efficacy of the process,”1-4 stated Kyle Malone, senior vice chairman, Scientific Affairs of Globus Medical. “We’ve got a real legacy to hold on as Globus Medical, and the deal with procedural innovation, surgeon partnership, analysis, and schooling that contributed to the success of XLIF will proceed to information future innovation whereas altering the lives of extra sufferers across the globe.”
Greater than 120 surgeons and {industry} leaders gathered at SMISS to rejoice the XLIF process. Hosted by NuVasive, the night occasion featured greater than 20 surgeon audio system discussing the previous, current and future influence of the process.
Dr. Frank Phillips, Rush College Medical Middle, has been an XLIF person since 2003. “XLIF has been some of the disruptive approaches to emerge within the spine area.” This surgical approach and its procedurally built-in portfolio of entry, interbody implants, fixation and enabling applied sciences proceed to reveal extra predictable outcomes than conventional spinal fusion procedures, with considerably fewer problems.5–9
“It’s exceptional how XLIF has continued to advance lateral, minimally invasive surgical functions,” stated Dr. Invoice Smith, neurosurgeon and early XLIF adopter who has accomplished over 1,800 XLIF procedures. “From its evolution of a one-level degenerative process to changing into the usual of care throughout a number of pathologies, XLIF has superior affected person care in traditionally difficult advanced, deformity, tumor and trauma circumstances.”
With ~300,000 procedures carried out, 200+ instructional programs hosted, 600+ peer-reviewed publications, and 60+ devoted merchandise launched, XLIF continues to vary affected person lives.
“I have a look at what XLIF has accomplished for minimally invasive surgical procedure and single-position surgical procedure, and I can solely think about what the way forward for innovation holds for the subsequent twenty years in lateral,” stated Dr. J. Alex Thomas, Atlantic Mind and Backbone.
Be taught extra in regards to the previous, current and way forward for the XLIF process right here.
- Sembrano JN, Tohmeh A, Isaacs R, et al. Two-year comparative outcomes of MIS lateral and MIS transforaminal interbody fusion within the remedy of degenerative spondylolisthesis: half I: medical findings. Backbone 2016;41(Suppl 8):S123-S132.
- Lehmen JA, Gerber EJ. MIS lateral spine surgical procedure: A scientific literature assessment of problems, outcomes, and economics. Eur Backbone J 2015;24(Suppl 3):287-313.
- Rihn JA, Patel R, Makda J, et al. Problems related to single-level transforaminal lumbar interbody fusion. Backbone J 2009;9(8):623-9.
- Lucio JC, VanConia RB, Deluzio KJ, et al. Economics of much less invasive spinal surgical procedure: an evaluation of hospital value variations between open and minimally invasive instrumented spinal fusion procedures throughout the perioperative interval. Threat Administration and Healthcare Coverage 2012;5:65-74.
- Lehmen JA, Gerber EJ. MIS lateral spine surgical procedure: A scientific literature assessment of problems, outcomes, and economics. Eur Backbone J 2015;24(Suppl 3):287-313.
- Cheng I, Briseno MR, Arrigo RT, et al. Outcomes of two totally different methods utilizing the lateral method for lumbar interbody arthrodesis. World Backbone J 2015;5(4):308-14.
- Khajavi Ok, Shen A, Lagina M, et al. Comparability of medical outcomes following minimally invasive lateral interbody fusion stratified by preoperative prognosis. Eur Backbone J 2015;24(Suppl 3):322-30.
- Okuda S, Miyauchi A, Oda T, et al. Surgical problems of posterior lumbar interbody fusion with complete facetectomy in 251 sufferers. J Neurosurg Backbone 2006;4(4):304-9.
- Scaduto AA, Gamradt SC, Yu WD, et al. Perioperative problems of threaded cylindrical lumbar interbody fusion units: anterior versus posterior method. J Spinal Disord Tech 2003;16(6):502-7.
About Globus Medical, Inc.
Globus Medical is dedicated to offering progressive applied sciences and industry-leading medical assist to assist surgeons and healthcare suppliers ship higher care across the globe. The Firm supplies some of the complete choices of musculoskeletal options and enabling applied sciences to influence the care continuum, now together with the procedurally built-in portfolio of NuVasive. The Firm’s workers are relentlessly targeted on advancing affected person care. For extra data, please go to www.globusmedical.com/uniting.
Secure Harbor Statements
All statements included on this press launch aside from statements of historic reality are forward-looking statements and could also be recognized by their use of phrases equivalent to “consider,” “might,” “may,” “might,” “will,” “goal,” “estimate,” “proceed,” “anticipate,” “intend,” “anticipate,” “plan” and different comparable phrases. These forward-looking statements are based mostly on our present assumptions, expectations and estimates of future occasions and traits. Ahead-looking statements are solely predictions and are topic to many dangers, uncertainties and different elements which will have an effect on our companies and operations and will trigger precise outcomes to vary materially from these predicted. These dangers and uncertainties embody, however will not be restricted to, the dangers and prices related to the mixing of, and the flexibility of Globus Medical and NuVasive to combine, their companies efficiently and to realize anticipated synergies, well being epidemics, pandemics and comparable outbreaks, together with the COVID-19 pandemic, elements affecting our quarterly outcomes, our skill to handle our progress, our skill to maintain our profitability, demand for our merchandise, our skill to compete efficiently (together with with out limitation our skill to persuade surgeons to make use of our merchandise and our skill to draw and retain gross sales and different personnel), our skill to quickly develop and introduce new merchandise, our skill to develop and execute on profitable enterprise methods, our skill to adjust to legal guidelines and laws which can be or might change into relevant to our companies, our skill to safeguard our mental property, our success in defending authorized proceedings introduced in opposition to us, traits within the medical machine {industry}, common financial situations, and different dangers. For a dialogue of those and different dangers, uncertainties and different elements that would have an effect on our outcomes, you need to confer with the disclosure contained in our most up-to-date annual report on Kind 10-Ok filed with the Securities and Change Fee, together with the sections labeled “Threat Elements” and “Cautionary Observe Regarding Ahead-Wanting Statements,” and in our Kinds 10-Q, Kinds 8-Ok and different filings with the Securities and Change Fee. These paperwork can be found at www.sec.gov. Furthermore, we function in an evolving atmosphere. New threat elements and uncertainties emerge on occasion and it isn’t potential for us to foretell all threat elements and uncertainties, nor can we assess the influence of all elements on our enterprise or the extent to which any issue, or mixture of things, might trigger precise outcomes to vary materially from these contained in any forward-looking statements. Given these dangers and uncertainties, readers are cautioned to not place undue reliance on any forward-looking statements. Ahead-looking statements contained on this press launch communicate solely as of the date of this press launch. We undertake no obligation to replace any forward-looking statements because of new data, occasions or circumstances or different elements arising or coming to our consideration after the date hereof.
Investor contact:
Brian Kearns
610-930-1800
buyers@globusmedical.com
Media contact:
Melanie Ordoñez
858-722-3899
media@globusmedical.com
Discussion about this post